BUD13P1

Across TCGA pan-cancer cohorts, BUD13P1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated BUD13P1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher BUD13P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BUD13P1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUAD show a favorable association.

BLCA, PAAD, and LGG are the cancer types where BUD13P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	IV	0.243	0.640	<.001	88	view →
PAAD	OS	Tertile	All	0.288	0.586	.001	50	view →
LGG	DFS	Median	All	0.652	0.820	<.001	48	view →
UVM	DFS	Median	III,IV	0.280	0.617	.018	26	view →
UCEC	DFS	Quartile	All	0.540	0.656	.004	22	view →
ESCA	OS	Tertile	III,IV	0.701	0.331	.005	20	view →
LUAD	OS	Quartile	III,IV	0.842	0.432	.003	20	view →
SKCM	OS	Quartile	III,IV	0.588	0.245	.001	15	view →
DLBC	OS	Tertile	All	0.445	1.000	.011	14	view →
BRCA	DFS	Median	III,IV	0.854	0.729	.005	14	view →
CHOL	DFS	Median	III,IV	0.127	0.647	.006	12	view →
CESC	OS	Quartile	IV	0.702	0.231	.014	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

BUD13P1–BLCA (DFS)

Open the BLCA breakdown →